Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ·Healthcare·Biotechnology
$12.44
+3.07%
Mkt Cap $261.88M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$48.20
Range $20.00 – $87.00
Implied Upside
+287.5%
Consensus $48.20 vs current $12.44
NASDAQ·Healthcare·Biotechnology
$12.44
+3.07%
Mkt Cap $261.88M
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$48.20
Range $20.00 – $87.00
+287.5%
Consensus $48.20 vs current $12.44